Lichan Tao

2.3k total citations · 1 hit paper
31 papers, 1.6k citations indexed

About

Lichan Tao is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Lichan Tao has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 19 papers in Molecular Biology and 12 papers in Cancer Research. Recurrent topics in Lichan Tao's work include Cardiovascular Function and Risk Factors (10 papers), Cardiac Fibrosis and Remodeling (8 papers) and MicroRNA in disease regulation (7 papers). Lichan Tao is often cited by papers focused on Cardiovascular Function and Risk Factors (10 papers), Cardiac Fibrosis and Remodeling (8 papers) and MicroRNA in disease regulation (7 papers). Lichan Tao collaborates with scholars based in China, United States and Netherlands. Lichan Tao's co-authors include Fei Hua, Jian‐Jun Li, Jiani Xu, Tingting Wang, Junjie Xiao, Yihua Bei, Xinli Li, Haifeng Zhang, Saumya Das and Shutong Shen and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Lichan Tao

31 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations

2022 549 citations Lichan Tao, Jiani Xu et al. Cardiovascular Diabetology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lichan Tao China	18	665	630	342	342	339	31	1.6k
Hisashi Makino Japan	27	634 1.0×	509 0.8×	417 1.2×	131 0.4×	171 0.5×	63	1.9k
Naifeng Liu China	27	657 1.0×	495 0.8×	304 0.9×	286 0.8×	285 0.8×	83	2.1k
Wenhui Peng China	23	593 0.9×	372 0.6×	152 0.4×	187 0.5×	249 0.7×	71	1.5k
Ling Yu China	20	420 0.6×	420 0.7×	304 0.9×	142 0.4×	187 0.6×	54	1.6k
Evis Harja United States	17	595 0.9×	253 0.4×	424 1.2×	132 0.4×	198 0.6×	20	2.0k
Hidemichi Kouzu Japan	21	536 0.8×	888 1.4×	170 0.5×	78 0.2×	185 0.5×	93	1.7k
Oliver Adam Germany	17	541 0.8×	785 1.2×	263 0.8×	158 0.5×	104 0.3×	28	1.7k
Alkistis Kapelouzou Greece	26	319 0.5×	580 0.9×	167 0.5×	154 0.5×	528 1.6×	68	1.8k
Gaoliang Yan China	20	709 1.1×	361 0.6×	247 0.7×	444 1.3×	151 0.4×	80	1.5k
Han Lei China	20	342 0.5×	371 0.6×	111 0.3×	167 0.5×	206 0.6×	55	1.3k

Countries citing papers authored by Lichan Tao

Since Specialization

Citations

This map shows the geographic impact of Lichan Tao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lichan Tao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lichan Tao more than expected).

Fields of papers citing papers by Lichan Tao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lichan Tao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lichan Tao. The network helps show where Lichan Tao may publish in the future.

Co-authorship network of co-authors of Lichan Tao

This figure shows the co-authorship network connecting the top 25 collaborators of Lichan Tao. A scholar is included among the top collaborators of Lichan Tao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lichan Tao. Lichan Tao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tao, Lichan, Hong Shu, Ying Wang, et al.. (2024). Inflammatory biomarkers predict higher risk of hyperglycemic crises but not outcomes in diabetic patients with COVID-19. Frontiers in Endocrinology. 15. 1287795–1287795. 4 indexed citations

Tao, Lichan, Zihan Qin, Lin Lin, et al.. (2023). Long noncoding RNA lncPostn links TGF-β and p53 signaling pathways to transcriptional regulation of cardiac fibrosis. American Journal of Physiology-Cell Physiology. 326(2). C457–C472. 2 indexed citations

Wang, Tingting, Jiani Xu, Hong Zhang, Lichan Tao, & Xiaolin Huang. (2023). Triglyceride-glucose index for the detection of subclinical heart failure with preserved ejection fraction in patients with type 2 diabetes. Frontiers in Cardiovascular Medicine. 10. 1086978–1086978. 10 indexed citations

Tao, Lichan, Jiani Xu, Tingting Wang, Fei Hua, & Jian‐Jun Li. (2022). Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovascular Diabetology. 21(1). 68–68. 549 indexed citations breakdown →

Gao, Rongrong, Lijun Wang, Yihua Bei, et al.. (2021). Long Noncoding RNA Cardiac Physiological Hypertrophy–Associated Regulator Induces Cardiac Physiological Hypertrophy and Promotes Functional Recovery After Myocardial Ischemia-Reperfusion Injury. Circulation. 144(4). 303–317. 97 indexed citations

Tao, Lichan, et al.. (2020). Identification of a lncRNA‑miRNA‑mRNA network based on competitive endogenous RNA theory reveals functional lncRNAs in hypertrophic cardiomyopathy. Experimental and Therapeutic Medicine. 20(2). 1176–1190. 11 indexed citations

Zhu, Yujiao, Wen Pan, Tingting Yang, et al.. (2019). Upregulation of Circular RNA CircNFIB Attenuates Cardiac Fibrosis by Sponging miR-433. Frontiers in Genetics. 10. 564–564. 98 indexed citations

Tao, Lichan, et al.. (2019). Reconstruction and Analysis of the lncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA Reveal Functional lncRNAs in Dilated Cardiomyopathy. Frontiers in Genetics. 10. 1149–1149. 29 indexed citations

Tao, Lichan, Long Wang, Xiaoyu Yang, Xiaohong Jiang, & Fei Hua. (2018). Recombinant human glucagon-like peptide-1 protects against chronic intermittent hypoxia by improving myocardial energy metabolism and mitochondrial biogenesis. Molecular and Cellular Endocrinology. 481. 95–103. 21 indexed citations

10.

Tao, Lichan, Yihua Bei, Yongqin Li, & Junjie Xiao. (2018). Neonatal Rat Cardiomyocytes Isolation, Culture, and Determination of MicroRNAs’ Effects in Proliferation. Methods in molecular biology. 1733. 203–213. 8 indexed citations

11.

Bei, Yihua, Lichan Tao, Dragoş Crețoiu, Sanda Maria Creţoiu, & Junjie Xiao. (2017). MicroRNAs Mediate Beneficial Effects of Exercise in Heart. Advances in experimental medicine and biology. 1000. 261–280. 13 indexed citations

12.

Tao, Lichan, Hui Wang, Xiuzhi Wang, Xiangqing Kong, & Xinli Li. (2016). Cardiac Telocytes. Current Stem Cell Research & Therapy. 11(5). 404–409. 18 indexed citations

13.

Tao, Lichan, Yihua Bei, Ping Chen, et al.. (2016). Crucial Role of miR-433 in Regulating Cardiac Fibrosis. Theranostics. 6(12). 2068–2083. 123 indexed citations

14.

Tao, Lichan, Yihua Bei, Haifeng Zhang, et al.. (2015). Exercise Training Protects Against Acute Myocardial Infarction via Improving Myocardial Energy Metabolism and Mitochondrial Biogenesis. Cellular Physiology and Biochemistry. 37(1). 162–175. 105 indexed citations

15.

Tao, Lichan, Siyi Fu, Xiuzhi Wang, et al.. (2015). Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice. Scientific Reports. 5(1). 8374–8374. 67 indexed citations

16.

Luo, Wen, Xia Zhao, Hengwei Jin, et al.. (2015). Akt1 signaling coordinates BMP signaling and β-catenin activity to regulate second heart field progenitor development. Development. 142(4). 732–742. 28 indexed citations

17.

Shen, Shutong, et al.. (2015). Qiliqiangxin Protects Against Cardiac Ischemia-Reperfusion Injury via Activation of the mTOR Pathway. Cellular Physiology and Biochemistry. 37(2). 454–464. 25 indexed citations

18.

Tao, Lichan, et al.. (2015). Tendency for age-specific mortality with hypertension in the European Union from 1980 to 2011.. PubMed. 8(2). 1611–23. 5 indexed citations

19.

Tao, Lichan, et al.. (2014). GW25-e3529 Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice. Journal of the American College of Cardiology. 64(16). C235–C236. 1 indexed citations

20.

Tao, Lichan, Shutong Shen, & Xinli Li. (2013). Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regeneration. Frontiers in Genetics. 4. 221–221. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact